
5 mg
Coming soon
BPC 157
5 mg
Hemi Pharma BPC 157 - Body Protection Compound 5mg vial
Price
£44.90
£42.65with Crypto -5% (5% off) Coming soon
Limited first batch. Reserve your spot now and you get first access when it lands. First come, first served.
Add 2 more product to unlock all payment methods.
Lovegra (Kamagra) [4Tab/100mg]£12.90
Kamagra Super£14.90Usage Injectable
Performance Profile
/ 5- Popularity5
Often Bought Together
Stack Deal+
+
Bundle Total3 items
£58.80£60.90
You save £2.10
Tick/untick items to customise your stack
Hand-picked for you
More from this lab
Frequently Asked Questions
What is Hemi Pharma BPC-157 and what does it do?
BPC-157 is a research peptide derived from a protein found in gastric juice. It is studied for its role in tissue repair and recovery, and is popular in the research and performance community for supporting tendon, ligament and gut healing. Hemi Pharma supplies it as a lyophilised vial.
How is BPC-157 typically used?
As a general guide and not medical advice, users commonly reconstitute the vial with bacteriostatic water and inject a low dose of around 250 to 500mcg once or twice daily, often near the area of concern or subcutaneously. Always confirm dosing with a qualified professional.
How do I reconstitute and store BPC-157?
BPC-157 comes as a freeze-dried powder that is mixed with bacteriostatic water before use. Once reconstituted it must be kept refrigerated. Always follow sterile technique and the guidance that comes with the product.
Do I need PCT or support with BPC-157?
No. BPC-157 does not suppress natural testosterone production and does not require PCT or an aromatase inhibitor. It is a recovery peptide, not a hormone, so the usual anabolic cycle rules do not apply.
Is this genuine Hemi Pharma stock and how fast does it ship?
Every vial of Hemi Pharma BPC-157 sold here is authentic and carries a verification check-code. Orders are dispatched from the UK on Royal Mail Tracked 24 in discreet packaging, with most deliveries arriving within one to two working days.


